UnitedHealth Group (NYSE:UNH) Given New $650.00 Price Target at Mizuho

UnitedHealth Group (NYSE:UNH) had its target price raised by Mizuho from $600.00 to $650.00 in a research report sent to investors on Wednesday,Benzinga reports. Mizuho currently has an outperform rating on the healthcare conglomerate’s stock.

UNH has been the subject of several other research reports. KeyCorp reaffirmed an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a report on Friday, January 10th. Truist Financial reduced their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, Piper Sandler cut their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Twenty-one analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $630.35.

UnitedHealth Group Trading Up 2.1 %

UNH traded up $12.12 during trading on Wednesday, reaching $590.62. The company had a trading volume of 5,012,509 shares, compared to its average volume of 4,337,137. UnitedHealth Group has a 12-month low of $436.38 and a 12-month high of $630.73. The firm’s 50-day simple moving average is $510.86 and its 200 day simple moving average is $541.73. The company has a market cap of $540.24 billion, a price-to-earnings ratio of 38.15, a PEG ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the prior year, the business earned $5.83 EPS. Equities research analysts anticipate that UnitedHealth Group will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.33% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of UNH. Greenfield Savings Bank lifted its position in shares of UnitedHealth Group by 1.1% during the 1st quarter. Greenfield Savings Bank now owns 5,951 shares of the healthcare conglomerate’s stock valued at $3,117,000 after acquiring an additional 64 shares during the period. Strategic Planning Group LLC lifted its stake in shares of UnitedHealth Group by 6.9% in the 1st quarter. Strategic Planning Group LLC now owns 10,918 shares of the healthcare conglomerate’s stock valued at $5,718,000 after purchasing an additional 703 shares during the period. Apella Capital LLC increased its stake in UnitedHealth Group by 44.1% in the first quarter. Apella Capital LLC now owns 1,682 shares of the healthcare conglomerate’s stock valued at $973,000 after purchasing an additional 515 shares in the last quarter. Hennion & Walsh Asset Management Inc. increased its holdings in shares of UnitedHealth Group by 2.2% during the first quarter. Hennion & Walsh Asset Management Inc. now owns 13,065 shares of the healthcare conglomerate’s stock valued at $6,843,000 after acquiring an additional 281 shares in the last quarter. Finally, Heritage Family Offices LLP lifted its position in UnitedHealth Group by 4.4% in the 1st quarter. Heritage Family Offices LLP now owns 2,921 shares of the healthcare conglomerate’s stock valued at $1,530,000 after acquiring an additional 124 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.